Di Nuzzo Private Wealth, Inc. Veracyte, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $658 Million
- Q2 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 5 shares of VCYT stock, worth $119. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5
Previous 2
150.0%
Holding current value
$119
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VCYT
# of Institutions
302Shares Held
78.1MCall Options Held
15.5KPut Options Held
16.7K-
Vanguard Group Inc Valley Forge, PA8.26MShares$198 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$187 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$126 Million0.27% of portfolio
-
Wellington Management Group LLP Boston, MA3.85MShares$92.4 Million0.02% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.8MShares$91.1 Million0.85% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.72B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...